アンジェス(株)【4563】の掲示板 2026/01/14〜2026/01/23

>>1103

すみませんでした。

お侍様、さんに、一からAI,習おうと思います。



> あのですねgoogle検索でもヒットする内容を⋯
> どのAIに問いを投げたか分かりませんが、敢えてなのかわざわざ下手くそなプロンプトで質問を投げるから まともな解答がでないのですよ^^;
> 主に周囲のページの内容ってなんですかwww
> そりゃAIも困りますよ(^^ゞ

>>1103

2020年の論文に、出てたみたいです。

感染性心内膜炎に関連してですかね。

Objectives: Labeled white blood cell scintigraphy is used in various clinical conditions. When there is suspicion of an infectious process, especially for bacterial agents, it has high specificity. It can be used in several conditions such as fever of obscure or undetermined origin, osteomyelitis screening and, in cardiology, when there is suspicion of infective endocarditis (IE) associated with the prosthesis. In 2015 it was included in the assessment of suspected IE patient in the Guideline of the European Society of Cardiology (ESC) in 2015. Labeled white blood cell scintigraphy SPECT-CT (WBCS) has demonstrated to be able to reduce the rate of misdiagnosed cases of IE. Few studies are published in a real-world scenario because the technique is not broadly available. The goal of this study is to describe the use of WBCS in a series of consecutive patients in a reference cardiovascular hospital to evaluate the clinical impact in the diagnostic workup of suspected endocarditis.




Journal of Nuclear Medicine May 2020, 61 (supplement 1) 649;です。